JP Stock MarketDetailed Quotes

4569 Kyorin Pharmaceutical

Watchlist
  • 1621
  • -14-0.86%
20min DelayMarket Closed Aug 22 15:00 JST
104.73BMarket Cap17.48P/E (Static)

Kyorin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyorin Pharmaceutical Q1 2025 Earnings Date

Currency：JPYJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
28.42B
+28.42B
Beat Est.
-100.00%
+2.03%
--
EPS
0
15.42
+15.42
Beat Est.
-100.00%
+30.57%
--
Analyst Rating
Underperform

May 13, 2024

Kyorin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jul 31, 20242025/Q128.419B / ----
Feb 6, 20242024/Q332.330B / ----
Aug 2, 20232024/Q127.854B / ----
Feb 6, 20232023/Q331.614B / ----
Aug 2, 20222023/Q124.619B / ----
DatePeriodRevenue/EstimateEarnings Call
Jul 31, 20242025/Q128.419B / ----
Feb 6, 20242024/Q332.330B / ----
Aug 2, 20232024/Q127.854B / ----
Feb 6, 20232023/Q331.614B / ----
Aug 2, 20222023/Q124.619B / ----

Unlock Free Earnings Estimates

Kyorin Pharmaceutical Earnings Reports

  • Kyorin Pharmaceutical: Supplementary financial data for the first quarter of the March 2025 period.

    Jul 31 02:00 ET

  • Kyorin Pharmaceutical: March 2025 quarter 1 financial results announcement [Japan standard] (consolidated)

    Jul 31 02:00 ET

  • Kyorin Pharmaceutical: Interim report

    Jun 28 02:30 ET

  • Kyorin Pharmaceutical: Confirmation letter

    Jun 24 02:51 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 13, 2024

    Underper form

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg